Non-alcoholic Fatty Liver Disease: all 1,507 studies
Page 6 of 16. Open to participants first (303), then studies with results posted, then the rest; newest registration first within each.
- Helicobacter Pylori Eradication in Non-diabetic Non-alcoholic SteatohepatitisCompletedNCT01654549Phase 2Results posted
- The Effect of Protein-enriched Diet on Body Composition and AppetiteCompletedNCT01634048Not applicableResults posted
- Intra-Individual Reproducibility of the Non-Invasive Assessment of the Portal CirculationCompletedNCT01579162Not applicableResults posted
- Cysteamine Bitartrate Delayed-Release for the Treatment of NAFLD in ChildrenCompletedNCT01529268Phase 2/3Results posted
- The Sleep, Liver Evaluation and Effective Pressure StudyCompletedNCT01482065Phase 2Results posted
- Study of Changes in Hepatic Fat Following Administration of MK-4074 and Pioglitazone Hydrochloride (MK-4074-008)CompletedNCT01431521Phase 1Results posted
- Rifaximin in Fatty Liver DiseaseTerminatedNCT01355575Phase 4Results posted
- Insulin Resistance in Non-alcoholic Fatty Liver DiseaseTerminatedNCT01289639Not applicableResults posted
- Fish Oil and Nonalcoholic Fatty Liver Disease (NAFLD) StudyCompletedNCT01285362Not applicableResults posted
- The Farnesoid X Receptor (FXR) Ligand Obeticholic Acid in NASH Treatment Trial(FLINT)CompletedNCT01265498Phase 2Results posted
- Prediction of Severity of Liver Disease by a 13C Octanoate Breath Test (OBT)TerminatedNCT01244503Phase 2Results posted
- Double-Blind, Placebo-Controlled Study of Two Doses of EPA-E in Patients With Non Alcoholic Steatohepatitis (NASH)CompletedNCT01154985Phase 2Results posted
- Colesevelam Versus Placebo in the Treatment of Nonalcoholic SteatohepatitisCompletedNCT01066364Phase 2Results posted
- LAGB as a Treatment for Morbid Obesity in AdolescentsCompletedNCT01045499Not applicableResults posted
- Adding Exenatide to Insulin Therapy for Patients With Type 2 Diabetes and Non-Alcoholic Fatty Liver DiseaseCompletedNCT01006889Phase 4Results posted
- Prevalence of Non-alcoholic Fatty Liver Disease (NAFLD) in Hispanics With Diabetes Mellitus Type 2 (T2DM) and Role of TreatmentCompletedNCT01002547Phase 4Results posted
- University of Texas H.S.C. San Antonio Pioglitazone in Non-Alcoholic Steatohepatitis Trial (UTHSCSA NASH Trial)CompletedNCT00994682Phase 4Results posted
- Liver Positron Emission Tomography (PET) Study of Non Alcoholic Fatty Liver DiseaseCompletedNCT00949403Early Phase 1Results posted
- Fish Oil and Diet for the Treatment of Non-Alcoholic Steatohepatitis (NASH)TerminatedNCT00845845Phase 2Results posted
- Treatment of Non Alcoholic Fatty Liver Disease With n-3 Fatty AcidsCompletedNCT00760513Phase 4Results posted
- Metformin for the Treatment of Nonalcoholic Fatty Liver Disease (NAFLD)TerminatedNCT00736385Phase 4Results posted
- Phase II Trial of Silymarin for Non-Cirrhotic Patients With Non-Alcoholic SteatohepatitisCompletedNCT00680407Phase 2Results posted
- Eltrombopag To Reduce The Need For Platelet Transfusion In Subjects With Chronic Liver Disease And Thrombocytopenia Undergoing Elective Invasive ProceduresTerminatedNCT00678587Phase 3Results posted
- Role of Exenatide in NASH-a Pilot StudyCompletedNCT00650546Phase 2/3Results posted
- Recombinant Leptin Therapy for Treatment of Nonalcoholic Steatohepatitis (NASH)CompletedNCT00596934Phase 2Results posted
- Pentoxifylline in Patients With Nonalcoholic SteatohepatitisCompletedNCT00590161Phase 2Results posted
- Endoscopic Ultrasound(EUS)-Guided TRUCUT Biopsy (EUS-TCB) of Suspected Nonalcoholic Fatty Liver Disease(NAFLD.)CompletedNCT00586313Not applicableResults posted
- A Study of Siliphos in Adults With Non-alcoholic Steatohepatitis (NASH)CompletedNCT00443079Phase 2Results posted
- Pentoxifylline/Nonalcoholic Steatohepatitis (NASH) Study: The Effect of Pentoxifylline on NASHCompletedNCT00267670Phase 2/3Results posted
- Obesity and Nonalcoholic Fatty Liver DiseaseCompletedNCT00262964Not applicableResults posted
- Insulin Resistance in Non-alcoholic Fatty Liver DiseaseTerminatedNCT00252499Not applicableResults posted
- Treatment of Nonalcoholic Fatty Liver Disease in Children (TONIC)CompletedNCT00063635Phase 3Results posted
- Pioglitazone vs Vitamin E vs Placebo for Treatment of Non-Diabetic Patients With Nonalcoholic Steatohepatitis (PIVENS)CompletedNCT00063622Phase 3Results posted
- Treating Nonalcoholic Steatohepatitis (NASH) With MetforminCompletedNCT00063232Phase 2Results posted
- Treating Nonalcoholic Steatohepatitis With PioglitazoneCompletedNCT00062764Phase 2Results posted
- Effect of Dapagliflozin on Metabolic Parameters in Patients With Non-Alcoholic Fatty Liver DiseaseCompletedNCT07881796Not applicable
- Brown Adipose Tissue Activity and NAFLD ProgressionCompletedNCT07825467
- Effects of Turkish Coffee and Green Tea in Fatty Liver DiseaseCompletedNCT07768956Not applicable
- Improvement in Hepatic Function Through Sumac (Rhus Coriaria L.) Supplement Along With a Calorie-restricted Diet for the Management of Grade-I Obese Non-alcoholic Fatty Liver Disease PatientsCompletedNCT07768657Not applicable
- Analysis of Renal Impairment Characteristics and High-Risk Factors in Chronic Hepatitis B Patients on Long-Term Oral Nucleos(t)Ide AnaloguesCompletedNCT07730905
- Comparative Effects of Mediterranean and DASH Diet on Hepatic FunctionCompletedNCT07622680Not applicable
- The Referral to Hepatology Can be Improved Through an Electronic Medical Record (EMR)-Based Best Practice Alert (BPA) for an Appropriate ReferralCompletedNCT07580482Not applicable
- Evaluating the Pharmacokinetics and Safety of MiricorilantCompletedNCT07553663Phase 1
- JiGenerations Health Cohort Study：Parental Exposure and Intergenerational Health in ChinaActive, not recruitingNCT07514377
- Study to Investigate the Effect of L. Lactis CKDB001 Administration on Liver Aminotransferases in Subjects With NAFLDCompletedNCT07378280Not applicable
- Measuring Amino Acid and Glucose Metabolism in Healthy Volunteers and NAFLD Patients Using Total-body PETActive, not recruitingNCT07366710Not applicable
- A Study Between Dapagliflozin and Empagliflozin Effect on NAFLD in Patients With Type 2 Diabetes.CompletedNCT07363707Phase 4
- Comparative Effects of Aspirin, Metformin and SGLT2 Inhibitors on Liver Enzymes, Lipid Profile, and FibroScan Findings in Non-Alcoholic Fatty Liver DiseaseCompletedNCT07338331Not applicable
- A Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Immunogenicity of Efimosfermin Alfa Administered as a Single Dose to Healthy Participants of Chinese, Japanese, and White/European AncestryCompletedNCT07335198Phase 1
- Impact of Lifestyle Interventions on Cognitive Decline in Non-alcoholic Fatty Liver DiseaseCompletedNCT07294963Not applicable
- Association of SGLT2 Inhibitors Therapy With Elastographic and Molecular Markers of Liver Injury in Type 2 DiabetesCompletedNCT07269197
- Assessment of Hepatic Steatosis Using Dedicated Software Implemented on Ultrasound DevicesCompletedNCT07268937
- Ultrasound-Based Estimation of Hepatic Steatosis in Pediatric MASLDCompletedNCT07265011Not applicable
- Shared Pathways Between Non-Alcoholic Fatty Liver Disease and Psoriatic Disease With Guselekumab TherapyWithdrawnNCT07255781
- A Research Study of a Potential New Medicine (NNC4005-0001) for Liver Disease in Adult Participants With Increased Body Weight and Liver FatActive, not recruitingNCT07214870Phase 1
- Effect of Adding TENS to Mediterranean Diet on Appetite and Liver Enzymes in Nonalcoholic Fatty Liver PatientsCompletedNCT07200934Not applicable
- The Impact of Hepatic Steatosis on Survival After PancreaticoduodenectomyCompletedNCT07182136
- Non-Invasive MASLD Diagnosis & T2D Remission BiomarkersActive, not recruitingNCT07172997
- PolyCystic Ovary Syndrome as Suggested Risk Group for Non-Alcoholic Fatty Liver DiseaseCompletedNCT07146815Not applicable
- Comparison of Effectiveness of Obeticholic Acid With Vitamin E in Patients of Non-alcoholic Fatty Liver DiseaseCompletedNCT07104786Phase 2
- MHT and Liver Function in Postmenopausal WomenCompletedNCT07103603Not applicable
- Liver Stiffness And Steatosis Assessment In Women With Polycystic Ovary Syndrome Using FibroscanCompletedNCT07027332
- Phase II Study Evaluating the Efficacy and Safety of DR10624 Injection in MASLD and MetALD SubjectsActive, not recruitingNCT07024212Phase 2
- Dapagliflozin in Nonalcoholic Fatty Liver Disease (NAFLD) and Type 2 Diabetes Mellitus Patients (T2DM).Active, not recruitingNCT07020377Phase 1/2
- Digital Therapy for Fatty Liver DiseaseActive, not recruitingNCT07007741Not applicable
- GLP-1 RA on Liver OMICS in MASLDWithdrawnNCT06982378
- Mechanisms of Macrophage Polarization in HIRI in Patients With NAFLDActive, not recruitingNCT06950710
- Evaluation of Miricorilant on Liver Fat in Patients With MASLDCompletedNCT06947304Phase 1
- Hepatoprotective Measures for Children at High Risk of NAFLDActive, not recruitingNCT06918080Phase 4
- The Ameliorative Effect of C-Kit (+) Hepatic Endothelial Cells With Mertk Deficiency on Nonalcoholic SteatohepatitisActive, not recruitingNCT06913699
- Optimizing Noninvasive assessMent Of DysmEtabolic Compensated Advanced Liver DiseaseActive, not recruitingNCT06888310Not applicable
- FibroScan-Reproducibility and Repeatability StudyCompletedNCT06877026Not applicable
- Hepatocellular Carcinoma 3 Gene Methylation Combination Detection Kit (PCR Fluorescent Probe Method) Multicenter Clinical TrialActive, not recruitingNCT06842563
- : Identification of Non-alcoholic Steato-hepatitis Cases in a Sample of Type 2 Diabetes Patients, with a Disruption of the Liver Function Tests, At the Pointe-à-Pitre University HospitalCompletedNCT06738810Not applicable
- Efficacy and Tolerability of a Specialized Food Products for Dietary Therapeutic and Preventive Nutrition Based on Ice Cream (Ice Cream With Brazzein, Maltitol and Oligofructose; Ice Cream With Brazzein, Erythritol, Maltitol and Inulin) Compared to Standard (Sundae) Ice CreamActive, not recruitingNCT06724913Not applicable
- Assessment of FibbroScan in Diagnosing MASLD Among the Chinese Population With ObesityCompletedNCT06720766
- Safety, Tolerability, and Pharmacokinetics of ACT500 in Healthy Adult ParticipantsCompletedNCT06716905Phase 1
- To Investigate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of BAR502 in Healthy SubjectsCompletedNCT06705998Phase 1
- Effects of Phytosterol Supplementation on Liver Function and Inflammatory Status in Patients With Nonalcoholic Fatty Liver DiseaseCompletedNCT06697977Not applicable
- A Phase 3 Study Evaluating the Safety and Efficacy of Denifanstat in Patients With MASLD and MASHWithdrawnNCT06692283Phase 3
- NASH Patient's Itinerary: Comparison of Strategies for Screening, Referring and Management of Diabetic PatientsCompletedNCT06688149Not applicable
- Raspberry Ketone Intake Upregulates Circulating FGF21 and Induces Energy Expenditure in HumansCompletedNCT06681597Early Phase 1
- Evaluating the Efficacy and Safety of Roflumilast in Patients with NASHCompletedNCT06677788Phase 2
- Intermittent Fasting Versus Diet to Stop Hypertension on Metabolic Risk Profile in Nonalcoholic Fatty Liver PatientsCompletedNCT06666894Not applicable
- Effectiveness of Nutrition Education Program and Omega-3 Supplementation Among Non-alcoholic Fatty Liver Disease PatientsCompletedNCT06627114Not applicable
- Efficacy and Safety of Pemafibrate for Nonalcoholic Fatty Liver DiseaseActive, not recruitingNCT06623539Phase 2
- Tocotrienol as a Treatment for Non-alcoholic Fatty Liver DiseaseCompletedNCT06596382Not applicable
- A Phase 3 Study Evaluating the Safety and Efficacy of Denifanstat in Patients With MASH and F2/F3 FibrosisWithdrawnNCT06594523Phase 3
- Dietary Intervention for Low Free Sugars in Children With Non-alcoholic Fatty Liver DiseaseCompletedNCT06579729Not applicable
- Ultrasound and Attenuation ImagingCompletedNCT06552377
- Effect of a GnRH Analog on Hepatic SteatosisActive, not recruitingNCT06523530Phase 4
- Nutritional Education Program for Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)Active, not recruitingNCT06503120Not applicable
- Prevalence of Steatosis and Steatohepatitis in Patients Undergoing Bariatric Surgery; a Biopsy-based StudyCompletedNCT06499675
- Probiotic Supplement Versus Placebo for the Treatment of Patients With Non-alcoholic Fatty Liver DiseaseCompletedNCT06491342Not applicable
- A Clinical Study of Efinopegdutide in People With Compensated Cirrhosis Due to Steatohepatitis (MK-6024-017)CompletedNCT06465186Phase 2
- Prevalence of NAFLD in T2DM PatientsActive, not recruitingNCT06445335Not applicable
- A Clinical Trial of Chazhu Xiaozhi Decoction Against Non-alcoholic Fatty Liver DiseaseCompletedNCT06442137Phase 2
- A Study to Evaluate DD01 in Overweight/Obese Subjects With MASLD/MASHCompletedNCT06410924Phase 2
- EndoNAFLD: Relationship Between Fatty Liver Disease and Cardiovascular DiseasesCompletedNCT06392828
- Effects of Tomato Consumption on Steatosis, Intestinal Function and Glucose and Lipid Metabolism in Subjects With NAFLDCompletedNCT06389851Not applicable